Viewing StudyNCT04550130



Ignite Creation Date: 2024-05-06 @ 3:12 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04550130
Status: RECRUITING
Last Update Posted: 2022-11-08
First Post: 2020-04-09

Brief Title: Dose-Evaluation Study of the Efficacy and Safety of TLA Gut Leukapheresis Treatment in Patients With Ulcerative Colitis
Sponsor: TLA Targeted Immunotherapies AB
Organization: TLA Targeted Immunotherapies AB

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12
Start Date Type: ESTIMATED
Primary Completion Date: 2023-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-12
Completion Date Type: ESTIMATED
First Submit Date: 2020-04-09
First Submit QC Date: September 14 2020
Study First Post Date: 2020-09-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-11-07
Last Update Post Date: 2022-11-08
Last Update Post Date Type: ACTUAL